Argenx highlights breadth of autoimmune pipeline with new multifocal motor neuropathy data at 2024 peripheral nerve society annual meeting

Arda study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (mmn) patients

ARGX Ratings Summary

ARGX Quant Ranking